Zavattarello, Italy

Massimo Di Nicola


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Massimo Di Nicola: Innovating Cancer Immunotherapy in Zavattarello, Italy

Introduction: Massimo Di Nicola is an accomplished inventor based in Zavattarello, Italy, renowned for his contributions to the field of cancer immunotherapy. His innovative work focuses on addressing significant challenges in the treatment of cancer, particularly in developing therapies that have lower toxicity and can overcome drug resistance.

Latest Patents: Massimo holds a patent for a groundbreaking invention titled "Bispecific Antibody Binding TRAIL-R2 and CD3." This novel approach involves bispecific antibodies capable of binding to both the TRAIL tumor-associated antigen and T lymphocyte CD3, offering promising implications for cancer treatment. His invention also includes compositions that comprise these bispecific antibodies and a labeling agent, as well as pharmaceutical compositions for tumor treatment.

Career Highlights: Massimo Di Nicola is affiliated with the Fondazione IRCCS Istituto Nazionale dei Tumori, a leading institution specializing in cancer research and treatment. His work at this prestigious organization highlights his commitment to advancing cancer therapies. With one patent to his name, his expertise in antibody technology positions him as a vital contributor to oncological research.

Collaborations: In his research endeavors, Massimo collaborates with esteemed professionals such as Mariangela Figini and Alessandro Satta. These partnerships enhance the innovative capacity of his work and facilitate the development of effective cancer therapies.

Conclusion: Massimo Di Nicola's dedication to cancer immunotherapy and his innovative patent for bispecific antibodies represent significant strides in treating tumors with reduced toxicity. His work at the Fondazione IRCCS Istituto Nazionale dei Tumori and collaborations with talented professionals underscore his role as a key player in the fight against cancer. As the field of immunotherapy continues to evolve, the impact of his contributions will undoubtedly be profound.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…